ArticleCancers2024

The Vimentin-Targeting Drug ALD-R491 Partially Reverts the Epithelial-to-Mesenchymal Transition and Vimentin Interactome of Lung Cancer Cells.

Marieke Rosier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.